Document ID: chunk:federal_register_of_legislation:F2024L01211:clause:1_4
Version: federal_register_of_legislation:F2024L01211
Segment Type: clause
Provision Reference: sch 1 cl 4
Character Range: 1664–2232

4  Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) British Pharmacopoeia;
(b) European Pharmacopoeia;
(c) export only medicine;
(d) standard;
(e) United States Pharmacopoeia-National Formulary.
  In this instrument:
Act means the Therapeutic Goods Act 1989.
Japanese Pharmacopoeia means the English edition of the publication of that name, published by the Japanese Pharmaceuticals and Medical Devices Agency or any replacement body, as in force or existing from time to time.